Clinical Trials Logo

Coronary Artery Stent Thrombosis clinical trials

View clinical trials related to Coronary Artery Stent Thrombosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01689493 Completed - Patient Compliance Clinical Trials

Strategy to Improve Antiplatelet Therapy Adherence After Coronary Stent Implantation

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness of an adherence protocol intervention among stented patients to improve adherence to antiplatelet therapy (primary endpoint). Secondary endpoints will assess whether the intervention reduces cardiovascular events (ACS, stent thrombosis, re- hospitalization and coronary angiography, revascularization, all-cause mortality) and its cost-effectiveness.

NCT ID: NCT01012544 Completed - Clinical trials for Coronary Artery Stent Thrombosis

Platelet Reactivity in Stent Thrombosis Patients

MAPCAT
Start date: April 2009
Phase: Phase 4
Study type: Interventional

Recent studies have demonstrated a marked interindividual variability of clopidogrel's capacity to inhibit platelet aggregation with a substantial proportion (11-34%) of the patients considered non-responders to clopidogrel treatment. Variable intestinal absorption is suggested to contribute to the inconsistencies in response to clopidogrel. However, little is known about intestinal absorption in subjects who had suffered from a stent thrombosis. The MAPCAT-study has been designed to investigate whether plasma pharmacokinetics (represented by Cmax, Tmax and the AUC) after a 600 mg loading dose are significantly different between subjects who have suffered a stent thrombosis and subjects who have not suffered a stent thrombosis.